University of Manchester first-in-human study of graphene brain-mapping electrodes completes

INBRAIN Neuroelectronics/Graphene brain interface

The University of Manchester completed its first-in-human study of INBRAIN's graphene cortical interface used during awake brain tumour surgery to assess safety and signal quality. The ultra-thin graphene electrodes detected distinct high-frequency activity tied to individual speech sounds and worked with standard hospital recording systems; the study enrolled 10 patients with no device-related adverse events reported.

• First-in-human study of graphene-based cortical interface enrolled 10 patients at University of Manchester.
• Electrodes used during awake brain tumour surgery detected distinct high-frequency activity linked to individual speech sounds.
• No device-related adverse events; ultra-thin graphene electrodes compatible with standard hospital recording systems.